Polygenic risk of anthracycline-related cardiomyopathy in childhood cancer survivors: Report from children’s oncology group and childhood cancer survivor study. Article

Sharafeldin, Noha, Wang, Xuexia, Wang, Fan et al. (2023). Polygenic risk of anthracycline-related cardiomyopathy in childhood cancer survivors: Report from children’s oncology group and childhood cancer survivor study. . JOURNAL OF CLINICAL ONCOLOGY, 41(16_suppl), 12090-12090. 10.1200/jco.2023.41.16_suppl.12090

cited authors

  • Sharafeldin, Noha; Wang, Xuexia; Wang, Fan; Singh, Purnima; Zhou, Liting; Landier, Wendy; Hageman, Lindsey; Burridge, Paul; Yasui, Yutaka; Sapkota, Yadav; Hudson, Melissa M; Chow, Eric Jessen; Armenian, Saro; Neglia, Joseph Philip; Ritchey, Arthur Kim; Hawkins, Douglas S; Ginsberg, Jill P; Robison, Leslie L; Armstrong, Gregory T; Bhatia, Smita

authors

publication date

  • June 1, 2023

published in

keywords

  • 2.1 Biological and endogenous factors
  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • Cancer
  • Cardiovascular
  • Clinical Research
  • Genetics
  • Human Genome
  • Pediatric
  • Pediatric Cancer
  • Prevention
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 12090

end page

  • 12090

volume

  • 41

issue

  • 16_suppl